Literature DB >> 10720898

Exacerbation of renal failure due to hypothyroidism in a patient with ischemic nephropathy.

Y Makino1, T Fujii, S Kuroda, T Inenaga, Y Kawano, S Takishita.   

Abstract

A case of acute-on-chronic renal failure in a 70-year-old woman with ischemic nephropathy and primary hypothyroidism is presented. Her renal function became progressively worse as the level of serum creatinine increased from 283 to 628 micromol/l (3.2-7.1 mg/dl) within 8 months. Her thyroid function had been normal before the exacerbation of renal failure, but it was markedly reduced with a marked elevation of serum thyroid-stimulating hormone. Thyroid hormone replacement therapy resulted in rapid improvement of the renal function to 159 micromol/l (1.8 mg/dl) of serum creatinine. The development of primary hypothyroidism seemed to worsen the already impaired renal function in this case. We suggest the assessment of thyroid function in patients with unexplained deterioration of renal failure. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720898     DOI: 10.1159/000045587

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Gender impact on the correlations between subclinical thyroid dysfunction and hyperuricemia in Chinese.

Authors:  Jianping Zhang; Zhaowei Meng; Qing Zhang; Li Liu; Kun Song; Jian Tan; Xue Li; Qiang Jia; Guizhi Zhang; Yajing He
Journal:  Clin Rheumatol       Date:  2015-01-21       Impact factor: 2.980

2.  Gender impact on the correlations between Graves' hyperthyroidism and hyperuricemia in Chinese.

Authors:  Xuehui Liu; Jianping Zhang; Zhaowei Meng; Qiang Jia; Jian Tan; Guizhi Zhang; Xue Li; Na Liu; Tianpeng Hu; Pingping Zhou; Qing Zhang; Kun Song; Qiyu Jia
Journal:  Ir J Med Sci       Date:  2018-11-30       Impact factor: 1.568

Review 3.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

4.  Thyroid hormones modulate uric acid metabolism in patients with recent onset subclinical hypothyroidism by improving insulin sensitivity.

Authors:  Giovambattista Desideri; Raffaella Bocale; Anna Maria D'Amore; Giulia Carnassale; Stefano Necozione; Angela Barini; Antonella Barini; Celestino Pio Lombardi
Journal:  Intern Emerg Med       Date:  2019-03-13       Impact factor: 3.397

5.  Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism.

Authors:  Dong Ho Shin; Mi Jung Lee; Hye Sun Lee; Hyung Jung Oh; Kwang Il Ko; Chan Ho Kim; Fa Mee Doh; Hyang Mo Koo; Hyoung Rae Kim; Jae Hyun Han; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

6.  Hypothyroidism causing paralytic ileus and acute kidney injury - case report.

Authors:  Chaturaka Rodrigo; Champika Sssk Gamakaranage; Dhanesha S Epa; Ariaranee Gnanathasan; Senaka Rajapakse
Journal:  Thyroid Res       Date:  2011-02-08

7.  Hyponatremia in kidney transplant patients: its pathophysiologic mechanisms.

Authors:  Carlos G Musso; Alejandrina Castañeda; María Giordani; Cesar Mombelli; Silvia Groppa; Nora Imperiali; Guillermo Rosa Diez
Journal:  Clin Kidney J       Date:  2018-03-16

Review 8.  The Association with Subclinical Thyroid Dysfunction and Uric Acid.

Authors:  Yuling Xing; Linlin Yang; Jing Liu; Huijuan Ma
Journal:  Int J Endocrinol       Date:  2021-12-13       Impact factor: 3.257

9.  Dyslipidemia and serum mineral profiles in patients with thyroid disorders.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

10.  Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study.

Authors:  Yi-Cheng Chang; Chia Hsuin Chang; Yi-Chun Yeh; Lee-Ming Chuang; Yu-Kang Tu
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.